Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models (Q40486635)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models |
scientific article |
Statements
1 reference
Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models (English)
1 reference
Nehal S Parikh
1 reference
Mark A Currier
1 reference
Yonatan Y Mahller
1 reference
Lisa C Adams
1 reference
Betsy Di Pasquale
1 reference
Margaret H Collins
1 reference
Timothy P Cripe
1 reference
1 May 2005
1 reference
1 reference
44
1 reference
5
1 reference
469-478
1 reference
1 reference
Identifiers
1 reference
1 reference